E Karamatskos

Summary

Affiliation: University Medical Center Hamburg-Eppendorf
Country: Germany

Publications

  1. ncbi Drug safety and efficacy evaluation of sertindole for schizophrenia
    Evangelos Karamatskos
    University Medical Center Hamburg Eppendorf, Centre of Psychosocial Medicine, Department of Psychiatry and Psychotherapy, Martinistr 52, D 20246 Hamburg, Germany
    Expert Opin Drug Saf 11:1047-62. 2012
  2. ncbi Subjective well-being of patients with schizophrenia as a target of drug treatment
    E Karamatskos
    Department of Psychiatry and Psychotherapy, University Medical Center Hamburg Eppendorf, Martinistr 52, D 20246 Hamburg, Germany
    Curr Pharm Biotechnol 13:1490-9. 2012

Detail Information

Publications2

  1. ncbi Drug safety and efficacy evaluation of sertindole for schizophrenia
    Evangelos Karamatskos
    University Medical Center Hamburg Eppendorf, Centre of Psychosocial Medicine, Department of Psychiatry and Psychotherapy, Martinistr 52, D 20246 Hamburg, Germany
    Expert Opin Drug Saf 11:1047-62. 2012
    ..g., children, elderly, first-episode, treatment-refractory patients, etc.) are still needed for a precise understanding of the therapeutic benefits and its role in schizophrenia therapy...
  2. ncbi Subjective well-being of patients with schizophrenia as a target of drug treatment
    E Karamatskos
    Department of Psychiatry and Psychotherapy, University Medical Center Hamburg Eppendorf, Martinistr 52, D 20246 Hamburg, Germany
    Curr Pharm Biotechnol 13:1490-9. 2012
    ....